{"HALLMARK_INTERFERON_GAMMA_RESPONSE":0,"HALLMARK_HYPOXIA":1,"HALLMARK_UV_RESPONSE_DN":2,"HALLMARK_WNT_BETA_CATENIN_SIGNALING":3,"HALLMARK_HEME_METABOLISM":4,"HALLMARK_MITOTIC_SPINDLE":5,"HALLMARK_ANGIOGENESIS":6,"HALLMARK_ALLOGRAFT_REJECTION":7,"HALLMARK_KRAS_SIGNALING_UP":8,"HALLMARK_ESTROGEN_RESPONSE_LATE":9,"HALLMARK_COAGULATION":10,"HALLMARK_MYC_TARGETS_V1":11,"HALLMARK_KRAS_SIGNALING_DN":12,"HALLMARK_P53_PATHWAY":13,"HALLMARK_SPERMATOGENESIS":14,"HALLMARK_MYC_TARGETS_V2":15,"HALLMARK_COMPLEMENT":16,"HALLMARK_UNFOLDED_PROTEIN_RESPONSE":17,"HALLMARK_NOTCH_SIGNALING":18,"HALLMARK_APICAL_JUNCTION":19,"HALLMARK_ANDROGEN_RESPONSE":20,"HALLMARK_APOPTOSIS":21,"HALLMARK_UV_RESPONSE_UP":22,"HALLMARK_DNA_REPAIR":23,"HALLMARK_PANCREAS_BETA_CELLS":24,"HALLMARK_MYOGENESIS":25,"HALLMARK_INTERFERON_ALPHA_RESPONSE":26,"HALLMARK_CHOLESTEROL_HOMEOSTASIS":27,"HALLMARK_GLYCOLYSIS":28,"HALLMARK_G2M_CHECKPOINT":29,"HALLMARK_IL6_JAK_STAT3_SIGNALING":30,"HALLMARK_OXIDATIVE_PHOSPHORYLATION":31,"HALLMARK_PEROXISOME":32,"HALLMARK_FATTY_ACID_METABOLISM":33,"HALLMARK_IL2_STAT5_SIGNALING":34,"HALLMARK_E2F_TARGETS":35,"HALLMARK_PI3K_AKT_MTOR_SIGNALING":36,"HALLMARK_ESTROGEN_RESPONSE_EARLY":37,"HALLMARK_HEDGEHOG_SIGNALING":38,"HALLMARK_APICAL_SURFACE":39,"HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION":40,"HALLMARK_MTORC1_SIGNALING":41,"HALLMARK_TGF_BETA_SIGNALING":42,"HALLMARK_TNFA_SIGNALING_VIA_NFKB":43,"HALLMARK_XENOBIOTIC_METABOLISM":44,"HALLMARK_BILE_ACID_METABOLISM":45,"HALLMARK_PROTEIN_SECRETION":46,"HALLMARK_ADIPOGENESIS":47,"HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY":48,"HALLMARK_INFLAMMATORY_RESPONSE":49}